Portfolio Update

BLACKROCK INCOME AND GROWTH INVESTMENT TRUST PLC All information is at 31 December 2014 and unaudited. Performance at month end with net income reinvested. One Three One Since Three Five month months year 1 April years years 2012 Sterling: Share price 1.0% 2.9% 9.4% 45.7% 52.2% 62.1% Net asset value -0.7% 4.6% 8.0% 34.9% 45.6% 57.0% FTSE All-Share Total Return -1.6% 0.6% 1.2% 29.4% 37.3% 51.8% Sources: BlackRock BlackRock took over the investment management of the Company with effect from 1 April 2012. At month end Sterling: Net asset value - capital only: 173.98p Net asset value - cum income*: 178.02p Share price: 175.75p Total assets (including income): £49.1m Discount to cum-income NAV: 1.3% Net Gearing: nil Net yield**: 3.2% Ordinary shares in issue***: 26,479,268 Gearing range (as a % of net assets) 0-20% Ongoing charges****: 1.2% * includes net revenue of 4.04 pence per share ** based on an interim dividend of 2.20p per share for the financial year ending 31 October 2014 and a final dividend of 3.50p per share in respect of the year ended 31 October 2013. *** excludes 6,454,664 shares held in treasury. **** Calculated as a percentage of average net assets and using expenses, excluding performance fees and interest costs for the year ended 31 October 2014. Benchmark Sector Analysis Total assets (%) Support Services 10.6 Tobacco 9.9 Life Insurance 9.5 Oil & Gas Producers 9.1 Pharmaceuticals & Biotechnology 8.4 Travel & Leisure 8.0 General Retailers 6.0 Media 5.4 Banks 5.1 Mining 4.1 Household Goods & Home Construction 3.9 Non-Life Insurance 3.7 Food Producers 2.6 Electronic & Electrical Equipment 2.6 Financial Services 2.2 Beverages 2.1 Personal Goods 1.8 General Industrials 1.4 Net Current Assets 3.6 Total 100.0 Ten Largest Equity Investments Company Total assets(%) Royal Dutch Shell `B' 5.8 British American Tobacco 5.7 HSBC 5.1 AstraZeneca 4.5 Reed Elsevier 4.4 Imperial Tobacco 4.2 Rio Tinto 4.1 Prudential 3.7 Wolseley 3.5 Friends Life 3.4 Commenting on the markets, Adam Avigdori & Mark Wharrier representing the Investment Manager noted: Markets UK equities experienced a turbulent quarter but ended in positive territory. Concerns intensified around weak economic growth in Europe, magnified by worries that Mario Draghi and the ECB were becoming ineffective. The outlook was further confused by the collapse in the oil price, which has now more than halved from its peak; whilst this in part reflects supply issues from OPEC and the US, it is also a function of weaker than expected demand, notably from Asia. US economic data provided a bright spot and a commensurate tightening in policy from the Federal Reserve. Larger companies lagged mid and small caps over the quarter, dragged down by the resources sectors. The pharmaceuticals sector gave back some of its earlier gains as the prospect of M & A activity waned. The travel & leisure sector led the positive contributors, boosted by the fall in the oil price. Portfolio Performance The portfolio returned 4.6%* in the fourth quarter, outperforming the FTSE All-Share Index return of 0.6%. Over the 2014 calendar year the Company has outperformed the FTSE All Share index by 6.8%. A broad range of companies including Wolseley, Reed Elsevier, Dixons Carphone and Howdens Joinery, continued to meet or exceed earnings expectations and contributed positively to returns. Wolseley has continued to deliver strong revenue growth, particularly in the USA, whilst maintaining margins, Reed Elsevier has demonstrated the benefits of its consistent strategy, producing revenue growth and margin expansion at the same time as returning excess capital to shareholders. Recent purchases of Carnival and Cineworld also outperformed, whilst Shire added to relative performance as the shares fell following the withdrawal of Abbvie's bid, the portfolio holding was sold earlier in the year after the bid was announced. Detractors from performance were relatively modest and included the underweight position in Vodafone, which reported signs of an improvement in European demand. Investors speculated that the recent consolidation in the European telecoms market would result in improved pricing and returns on 4G capital expenditure. Elsewhere, Essentra fell following a third quarter update that showed weakness in its Porous Technologies business. Activity during the period included new purchases of Hays, Cineworld, DS Smith, Marks & Spencer and Diageo with additions to Friends Life and Next. We reduced Reckitt Benckiser and GlaxoSmithKline and sold Vodafone, Admiral and Aviva. Outlook Eurozone economic activity remains subdued despite an increasingly supportive policy response from the European Central Bank, whilst in the US the ending of quantitative easing is contributing to uncertainty. We continue to focus more on the specific drivers of individual companies and the ability to determine their future rather than relying on a specific macro outcome. Given the outlook for both economic growth and interest rates remains uncertain, we seek those companies that can drive returns through self-help and have a clear strategy to deploy the cashflow they generate. The portfolio is primarily invested in high free cash flow companies that can sustain cash generation and pay a growing dividend yield. It also has exposure to companies with sustainable growth franchises and turnaround situations. * NAV - Inc. performance. 19 January 2015
UK 100

Latest directors dealings